A novel per‐oral insulin formulation: proof of concept study in non‐diabetic subjects
Authors:
- 22 March 2004
- journal article
- Published by Wiley in Diabetic Medicine
- Vol. 21 (4) , 354-357
Abstract
Aims The aim of our study was to examine the absorption of insulin from the gastrointestinal (GI) tract, using a novel oral formulation—adding a delivery agent SNAC (sodium N‐[8‐(2‐hydroxybenzoyl)amino] caprylate) in combination with insulin.Methods Capsules containing insulin and SNAC, in various combinations, were administered orally, as a single dose, to 12 non‐diabetic subjects and four control subjects (receiving SNAC or insulin only) in order to assess its biological effect and safety. Plasma glucose levels, insulin and C‐peptide concentrations, as well as SNAC levels, were determined, at timed intervals up to 4 h.Results In all cases, a glucose‐lowering effect was demonstrated, preceded by an increase in plasma insulin levels. The nadir of plasma glucose levels appeared after 30–50 min, following the ingestion of the mixture. The plasma insulin levels were found to parallel the blood SNAC levels. Plasma C‐peptide levels were suppressed by the lowered glucose levels achieved concurrent with the increasing amount of exogenous insulin absorbed, indicating that the secretion of endogenous hormone was partially abolished. There were no biological effects regarding blood glucose levels upon administration of SNAC or insulin when given alone. No adverse effects were detected during the trial or several weeks after the trial.Conclusions Insulin in combination with a novel delivery agent, SNAC, given orally, is absorbed through the GI tract in a biologically active form. This was demonstrated by a glucose lowering effect of the mixture as well as a suppression of an endogenous insulin secretion.Keywords
This publication has 15 references indexed in Scilit:
- Insulin GlargineDrugs, 2001
- Hyperglycemic Crises in Patients With Diabetes MellitusDiabetes Care, 2001
- Insulin Aspart: A New Rapid-Acting Insulin AnalogAnnals of Pharmacotherapy, 2000
- Intestinal Absorption of Low Molecular Weight Heparin in Animals and Human SubjectsPathophysiology of Haemostasis and Thrombosis, 2000
- Thermodynamic characterization of an intermediate state of human growth hormoneProtein Science, 1998
- Comparison of LysB28, ProB29-Human Insulin Analog and Regular Human Insulin in the Correction of Incidental HyperglycemiaDiabetes Care, 1996
- A Comparison of the Effects of Selective Increases in Peripheral or Portal insulin on Hepatic Glucose Production in the Conscious DogDiabetes, 1996
- Oral Administration of Insulin in Solid Form to Nondiabetic and Diabetic DogsJournal of Pharmaceutical Sciences, 1994
- Gastrointestinal Parameters That Influence Oral MedicationsJournal of Pharmaceutical Sciences, 1993
- Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.BMJ, 1988